K Number
Device Name
Decision Date
Decision
Applicant
BD Phoenix Automated Microbiology System - GN Imipenem-relebactam (0.0625/4 - 16/4 µg/mL)
May 19, 2025
Substantially Equivalent
Becton, Dickinson and Company
VITEK COMPACT PRO
Mar 14, 2025
Substantially Equivalent
bioMerieux Inc.
BD Phoenix Automated Microbiology System
Mar 06, 2025
Substantially Equivalent
Becton, Dickinson and Company
BD Phoenix Automated Microbiology System - GN Ciprofloxacin (0.01564 µg/mL)
Mar 15, 2024
Substantially Equivalent
Becton, Dickinson and Company
VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL)
Mar 11, 2024
Substantially Equivalent
bioMerieux, Inc.
Colibrí
Dec 27, 2023
Substantially Equivalent
Copan WASP S.r.l.
VITEK 2 AST-Streptococcus Penicillin (<=0.06 - =>8 µg/mL), VITEK 2 Streptococcus Penicillin (<=0.06 - >=8 µg/mL), VITEK 2 Streptococcus Penicillin
Oct 23, 2023
Substantially Equivalent
bioMerieux, Inc
VITEK 2 AST-Gram Positive Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin
Jul 05, 2023
Substantially Equivalent
BioMerieux, Inc
VITEK 2 AST-Gram Negative Levofloxacin (</=0.125 ->/=8 ug/mL)
Jun 26, 2023
Substantially Equivalent
bioMerieux, Inc.
Selux AST System; Model AST Gen 1.0
Apr 19, 2023
Substantially Equivalent
Selux Diagnostics, Inc
VITEK 2 AST-Gram Negative Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin
Mar 09, 2023
Substantially Equivalent
bioMerieux SA, Inc.
VITEK® 2 AST-Gram Negative Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin
Feb 16, 2023
Substantially Equivalent
bioMerieux, Inc
VITEK 2 AST-Gram Negative Cefazolin (<=1 - >=32 ug/mL)
Feb 09, 2023
Substantially Equivalent
bioMerieux, Inc
VITEK® 2 Streptococcus Tetracycline (<=0.25 - >=16 µg/mL)
Feb 03, 2023
Substantially Equivalent
bioMerieux, Inc
VITEK 2 AST-Gram Positive Moxifloxacin (=0.25 - =8 µg/ml), VITEK 2 AST-GP Moxifloxacin (=0.25 - =8 µg/mL), VITEK 2 AST-GP Moxifloxacin
Jan 27, 2023
Substantially Equivalent
bioMerieux, Inc
Selux AST System; Model AST Gen 1.0
Jan 18, 2023
Substantially Equivalent
Selux Diagnostics, Inc.
VITEK 2 AST-Gram Positive Cefoxitin Screen
Oct 13, 2022
Substantially Equivalent
bioMerieux, Inc
Colibrí System
Oct 05, 2022
Substantially Equivalent
Copan WASP S.r.l.
VITEK 2 AST- Gram Positive Telavancin (<=0.015 - >=1 µg/mL)
Aug 08, 2022
Substantially Equivalent
bioMerieux, Inc
VITEK 2 AST-Yeast Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin
Jul 12, 2022
Substantially Equivalent
bioMerieux, Inc.
VITEK 2 AST-Gram Negative Omadacycline (<=0.25 - >=16 µg/mL)
Jun 03, 2022
Substantially Equivalent
bioMerieux, Inc.
VITEK 2 AST-Gram Negative Ciprofloxacin (?0.06 - ?4 µg/mL)
Apr 14, 2022
Substantially Equivalent
bioMerieux, Inc
VITEK 2 AST-Yeast Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole
Feb 25, 2022
Substantially Equivalent
BioMerieux, Inc.
VITEK 2 AST-Gram Positive Linezolid (<=0.5 >=8 µg/mL)
Feb 04, 2022
Substantially Equivalent
bioMérieux, Inc
VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL)
Oct 28, 2021
Substantially Equivalent
bioMerieux, Inc
VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL)
Sep 14, 2021
Substantially Equivalent
bioMerieux, Inc.
VITEK 2 AST-Gram Negative Piperacillin / Tazobactam (<=4 - =>128 µg/mL)
Aug 30, 2021
Substantially Equivalent
bioMerieux, Inc
VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 µg/mL)
Jul 09, 2021
Substantially Equivalent
bioMerieux, Inc.
VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML)
Jun 14, 2021
Substantially Equivalent
BioMerieux, Inc
VITEK 2 AST-Gram Negative Ceftazidime (=<0.5 - =>32 µg/mL)
Sep 28, 2020
Substantially Equivalent
BioMerieux, Inc.
LabPro Data Management System
Aug 30, 2020
Substantially Equivalent
Beckman Coulter Inc.
VITEK 2 AST-Gram Positive Delafloxacin (<=0.015 - >=1 µg/mL)
Apr 28, 2020
Substantially Equivalent
bioMerieux, Inc
VITEK 2 AST-Gram Negative Imipenem/Relebactam (<=0.25/4 - >=16/4 µg/mL)
Mar 13, 2020
Substantially Equivalent
BioMerieux, Inc.
VITEK 2 AST- Gram Negative Polymyxin B (<=0.25 >=16 ug/mL)
Feb 14, 2020
Substantially Equivalent
BioMerieux, Inc.
Vitek Densichek
Oct 31, 2019
Substantially Equivalent
bioMerieux, Inc
VITEK 2 AST-Gram Negative Eravacycline (<=0.12 - >=4µg/mL)
Aug 05, 2019
Substantially Equivalent
bioMerieux, Inc.
BD Phoenix Automated Microbiology System GN Ceftaroline (0.0156-4 µg/mL)
Jul 01, 2019
Substantially Equivalent
Becton, Dickinson and Company
VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL)
Jun 06, 2019
Substantially Equivalent
bioMerieux, Inc.
VITEK2 AST-Gram Negative Delafloxacin (<=0.06->=4 ug/mL)
Mar 12, 2019
Substantially Equivalent
bioMerieux, Inc.
VITEK 2 AST-Gram Negative Minocycline (<= 0.5 - >= 32 ug/mL)
Mar 07, 2019
Substantially Equivalent
bioMerieux, Inc.
VITEK 2 AST-Gram Negative Meropenem/Vaborbactam (<=0.5/8 >=64/8 µg/mL)
Feb 26, 2019
Substantially Equivalent
bioMerieux, Inc
VITEK 2 AST-Gram Negative Imipenem (</=0.25->= 16 ug/mL)
Feb 20, 2019
Substantially Equivalent
bioMerieux, Inc.
VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance
Dec 10, 2018
Substantially Equivalent
bioMerieux, Inc
BD Phoenix Automated Microbiology System - BD Phoenix CPO detect - GN
Sep 21, 2018
Substantially Equivalent
Becton,Dickinson and Company
BD Phoenix Automated Microbiology System - GN Meropenem-vaborbactam (0.125/8-32/8 ug/mL)
Feb 09, 2018
Substantially Equivalent
Becton, Dickinson and Company
BD Phoenix Automated Microbiology System - GN Ceftolozane/tazobactam (0.25/4-32/4 ug/mL)
Jan 05, 2018
Substantially Equivalent
Becton, Dickinson, and Company
VITEK 2 AST-GN Ceftazidime/Avibactam <=0.12 >=16 µg/mL
Dec 19, 2017
Substantially Equivalent
bioMerieux, Inc.
VITEK 2 AST-GN Amikacin (<=1 ->=64 ug/mL)
Dec 08, 2017
Substantially Equivalent
bioMerieux, Inc.
VITEK 2 AST-GN Ciprofloxacin (<=0.06->=4µg/mL)
Jun 21, 2017
Substantially Equivalent
bioMerieux, Inc
BD Phoenix Automated Microbiology System - GN Ceftazidime/avibactam (0.25/4- 32/4ug/mL)
Mar 21, 2017
Substantially Equivalent
BECTON, DICKINSON & COMPANY